Work

P011. Impact of Patisiran on Activities of Daily Living and Functional Status in hATTR Amyloidosis

Year: 2021

Type: conference-abstract

Source: Heart & Lung

DOI: 10.1016/j.hrtlng.2021.03.066

Authors: Madeline Merkel, David Adams, Senda Ajroud-Driss, John Berk, Alejandra Gonzalez-Duarte, Cecilia Hale, Hollis Lin, Amanda Peltier, Ole Suhr, Ivailo Tournev, Taro Yamashita

Institutions: Alnylam Pharmaceuticals (United States), Inserm, Northwestern University, Boston University, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Vanderbilt University Medical Center, Umeå University, Alexandrovska Hospital, Kumamoto University Hospital

Language: English

Topic: Amyloidosis: Diagnosis, Treatment, Outcomes

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3167446545

Cites:

Cited by:

Related to: 10